Elanco Animal Health Inc (NYSE: ELAN) awarded derivative securities to Executive Vice President and Chief Financial Officer Robert M. VanHimbergen at $24.50 per share. The transaction represented about 5.4% of his resulting derivative-securities holding. The recipient is identified as an executive officer of Elanco …
Century Therapeutics, Inc. (NASDAQ: IPSC) has expanded its board with Joseph Truitt, granting him an initial option to purchase 148,000 common shares. Truitt’s appointment took effect on September 9, 2026, and he will also receive a $40,000 annual cash retainer as a non-employee director.
Century Therapeutics, Inc. (NASDAQ: IPSC) CEO Brent Pfeiffenberger forfeited 463 shares at $2.11 per share, leaving him with 3,633,839 shares. The transaction represented about 0.0% of his prior holding.
Carr Douglas, SVP Finance & Operations at Century Therapeutics, Inc. (NASDAQ: IPSC), sold 254 shares at $2.05 per share. The transaction occurred on 8 September 2026 and left Douglas holding 504,565 Century Therapeutics shares.
Ascendis Pharma A/S (NASDAQ: ASND) said once-weekly TransCon CNP produced a mean +3.15 mm change from baseline in the sagittal diameter of the foramen magnum in infants with achondroplasia. The Week 52 data also showed stabilization or improvement in cranio-cervical junction health alongside linear …
Protocol Adds Post-Treatment Weight-Regain Assessment
BIO-RAD LABORATORIES, INC. (NYSE: BIO) executive Eva Anette Engelhardt exercised options covering 2,179 shares at $0 per share across separate transactions. The reported records also show her ownership at 2,313 shares following those transactions.
BIO-RAD LABORATORIES, INC. (NYSE: BIO) recorded option exercises covering 320 shares at $0 per share in transactions dated 5 September 2026 and 6 September 2026. Allison Schwartz, a director, held 1,768 shares after those exercises.
The transaction left him with 2,631 shares, representing about 65.1% of his resulting shares holding.
Butterfly Network, Inc. (NYSE: BFLY) finance executive Megan Carlson sold 13,804 shares at $7.30 per share on 4 September 2026. Following the transaction, Carlson owned 412,085 shares.